TUBB2B and neoplasm: Importantly, our data showed that the intravenous administration of TUBB2B siRNA-AuNPs to mice resulted in a significant inhibition of tumor growth and brain metastatic colonization (Fig. 7F and G), demonstrating the preclinical efficacy of targeting TUBB2B for TNBC.